Anavex Life Sciences Corporation (AVXL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AVXL Giù? Forum Previsione Frazionamento azionario

Perché le azioni Anavex Life Sciences Corporation (AVXL) sono in ribasso?

Abbiamo notato un calo di 10.78% nelle azioni di Anavex Life Sciences Corporation (AVXL) durante la sessione di negoziazione di 2025-05-20. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-11-27:

Anavex Life Sciences Corporation Stock (AVXL) dropped by 10.04% from $7.07 to $6.36 in the trading on Monday November 27, 2023. The reasons why AVXL stock down today include:

Fourth-quarter financial results: Anavex Life Sciences reported a narrower net loss of $10.1 million for the fourth quarter of 2023, compared to $14.3 million in the year-ago quarter. The company's non-cash items decreased to $3.2 million from $6.0 million in the prior-year quarter, resulting in a net loss per share of 12 cents, down from 18 cents.
Shortage in key pipeline update: Anavex reported pipeline updates that excluded a clear timeline for one of its key development programs for lead drug blarcamesine. Without a specific timeline, the company said it is on track to release topline data from its ANAVEX 2-73-RS-003 Phase 2/3 EXCELLENCE clinical trial for blarcamesine in children with the neurological disorder Rett syndrome.

GMAB

$20.66

0.78%

RPRX

$36.03

0.45%

SMMT

$21.28

3.30%

INSM

$100.64

1.16%

BNTX

$106.47

0.23%

ONC

$242.07

0.36%

Anavex Life Sciences Corporation (AVXL)

Perché le azioni Anavex Life Sciences Corporation (AVXL) sono in ribasso?

Simile a AVXL